Chawner Stephen J, Cases-Thomas Manuel J, Bull James A
Department of Chemistry Imperial College London South Kensington SW7 2AZ London UK.
Lilly Research Centre Eli Lilly and Company Erl Wood Manor, Sunninghill Road GU20 6PH Windlesham UK.
European J Org Chem. 2017 Sep 15;2017(34):5015-5024. doi: 10.1002/ejoc.201701030. Epub 2017 Sep 11.
Cyclopropanes provide important design elements in medicinal chemistry and are widely present in drug compounds. Here we describe a strategy and extensive synthetic studies for the preparation of a diverse collection of cyclopropane-containing lead-like compounds, fragments and building blocks exploiting a single precursor. The bifunctional cyclopropane ()-ethyl 2-(phenylsulfanyl)-cyclopropane-1-carboxylate was designed to allow derivatization through the ester and sulfide functionalities to topologically varied compounds designed to fit in desirable chemical space for drug discovery. A cobalt-catalyzed cyclopropanation of phenyl vinyl sulfide affords these scaffolds on multigram scale. Divergent, orthogonal derivatization is achieved through hydrolysis, reduction, amidation and oxidation reactions as well as sulfoxide-magnesium exchange/functionalization. The cyclopropyl Grignard reagent formed from sulfoxide exchange is stable at 0 °C for > 2 h, which enables trapping with various electrophiles and Pd-catalyzed Negishi cross-coupling reactions. The library prepared, as well as a further virtual elaboration, is analyzed against parameters of lipophilicity (ALog P), M and molecular shape by using the LLAMA (Lead-Likeness and Molecular Analysis) software, to illustrate the success in generating lead-like compounds and fragments.
环丙烷是药物化学中的重要设计元素,广泛存在于药物化合物中。本文我们描述了一种利用单一前体来制备多种含环丙烷的类先导化合物、片段和构建单元的策略及广泛的合成研究。双功能环丙烷()-2-(苯硫基)-环丙烷-1-羧酸乙酯的设计目的是通过酯基和硫醚官能团进行衍生化,得到拓扑结构多样的化合物,这些化合物旨在契合药物发现中理想的化学空间。苯基乙烯基硫醚的钴催化环丙烷化反应可在多克规模上制备这些骨架结构。通过水解、还原、酰胺化和氧化反应以及亚砜-镁交换/官能化反应实现了不同的、正交的衍生化。由亚砜交换形成的环丙基格氏试剂在0℃下可稳定存在>2小时,这使得它能够与各种亲电试剂发生捕获反应以及钯催化的根岸交叉偶联反应。使用LLAMA(类先导性和分子分析)软件对所制备的化合物库以及进一步的虚拟扩展产物进行亲脂性(ALOG P)、M和分子形状参数分析,以说明在生成类先导化合物和片段方面的成功。